Microdose Presents The Mushroom Conference: A Molecular Masterclass

This article was originally published on Microdose Psychedelic Insights and appears here with permission.

Microdose is pleased to announce The Mushroom Conference: A Molecular Masterclass is only days away! This exciting virtual event features over 70 world class speakers and will spotlight the dynamic field of psilocybin therapy as well as functional and edible mushrooms. Between the exciting developments unfolding in the world of psilocybin science to major policy wins and market interest, the magical world of mushrooms is more exciting than ever before. Grab your tickets today and join us for this special event taking place on November 20-22nd. 

wins and market interest, the magical world of mushrooms is more exciting than ever before. Grab your tickets today and join us for this special event taking place on November 20-22nd. 

Microdose is pleased to offer an exclusive 30% discount on General Admission tickets to the Mushroom Conference for our Benzinga readers.

A Sneak Peek At Our Upcoming Panels, Sponsor Presentations & Keynotes 

The Mushroom Conference will feature a variety of expert panels that cover a wide range of topics, including advanced mycological research, medicinal mushrooms,  mycotoxicology, food mycology, fungal biotechnology, bacterial-fungal interactions, fungal pathogens, clinical mycology, mushroom cultivation, the latest clinical research featuring psilocybin, exciting investment opportunities, and much more. 

In addition to our all-star speaker lineup, there will also be dynamic presentations from our sponsors, such as MagicMed Industries, Wake Network, PsyGen Labs, Pilz Biosciences, ACS Pharmacology & Translational Science, and Empyrean. Dynamic keynote addresses will be given by leading experts, including world-renowned ethnopharmacologist Dr. Dennis McKenna! You definitely don’t want to miss this incredible opportunity to gain deep insights into the mushroom sector. 

From De-Regulation to Deeper Research: Psilocybin Is Winning Big

Between the historic legislation approving psilocybin therapy in Oregon and the groundbreaking new studies demonstrating psilocybin’s efficacy in treating depression, there is certainly no shortage of exciting developments about ‘shrooms in this dynamic space. This innovative masterclass will feature deep insights from leading scientists, researchers and luminaries in the industry, such as. Dr. Stephen Barnhill of Aion Therapeutic, Dr. Jackie Salm of Psilera Biosciences, Dr. Marvin Hausman of Pilz Bioscience Corp and many others. Sam Chapman, the activist leading the charge to legalize psilocybin in Oregon will also be speaking. From major policy advancements to the latest cutting-edge research, The Mushroom Conference is sure to illuminate and inspire!

The Market for Fungi is Rapidly Mushrooming and Investors Are Interested 

The market for edible, functional, and psychoactive mushrooms is set to skyrocket in the coming years. From their fascinating role as groundbreaking mental health medicines to their unique culinary and adaptogenic applications, the global fungi industry is set to mushroom into an $86 billion dollar industry by 2025. In fact, the mushroom market pulled in over $53.7 billion in 2019 alone. Additionally, just this month, the medical mushroom company Cybin Corp recently announced closing Canada’s largest ever go-public financing in the psychedelic sector with gross proceeds totaling CDN $45 million. Between these developments and the monumental strides made by players like Compass Pathways, the emerging mushroom market couldn’t possibly be more active and attractive to investors.

The “Shroom Boom” Has Major Advantages Over the Cannabis “Green Rush” 

Endearingly dubbed the “shroom boom”, the phenomenon is following a similar course to the “green rush” exhibited by cannabis–but with some major advantages. Most notably, when it comes to psilocybin, the body of scientific and clinical research far outweighs that of cannabis. The results from those studies also show remarkable promise in the treatment of serious mental illness, which is fueling significant investor interest. Additionally, the emerging psychedelic industry has drawn in major players and serious talent from the cannabis sector. Indeed, The Mushroom Conference spotlights many of these dignitaries, including Dustin Robinson of Mr. Psychedelic Law and founder of Mr. Cannabis Law, Del Potter of Aya Biosciences (advised at top cannabis and pharmaceutical companies) and Irie Selkirk, Chief Communications Officer for SheCann–a female focused medical cannabis advocacy group. These thought leaders bring forth a versatile skill set from the cannabis industry, giving the emerging mushroom sector a massive advantage over cannabis. All these wonderful thought leaders and many more will be featured at the upcoming conference. 

Microdose is pleased to offer an exclusive 30% discount on General Admission tickets to the Mushroom Conference for our Benzinga readers.

Looking Ahead to The Magical World of Mushrooms at The Mushroom Conference

The incredible progress being made by the mushroom industry comes at a critical time in our species collective evolution. Amidst the current global pandemic, mental health crisis, and opioid epidemic, there is a greater need for new medicines and wellness products than ever before. For all the deepest insights and latest updates into the burgeoning mushroom industry, join us at The Mushroom Conference: A Molecular Masterclass!

Bonus: A Real-Time Update on our Upcoming Documentary “The World on Drugs”

In addition to our dynamic speaker lineup, Microdose will be providing a real-time update on our upcoming documentary feature film “The World on Drugs”. With the team returning from filming the second leg of the journey in Vancouver, there are certainly some exciting developments to share. From our insightful encounter with the renowned Dr. Gabor Maté to our interview with the legendary Paul Stamets, “The World on Drugs” brings forth the powerful potential of psychedelic medicine by illuminating the most inspiring voices in the space.

Microdose is pleased to offer an exclusive 30% discount on General Admission tickets to the Mushroom Conference for our Benzinga readers."

Read the original Article on Microdose Psychedelic Insights.

Benzinga's Related Links: 

• Will Cannabis Entrepreneurs Switch To Psychedelics?
• Suddenly, Psychedelics Are Big Business
• Más de Microdose Psychedelic Insights en Español en El Planteo